Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richman

Showing results (411-420 of 792) with videos related to

Pageof 80
Sort By:
JAMA Oncology|October 28, 2017
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal CancerJenny F Seligmann, Ace J Hatch, Susan D Richman, et al.
The Journal of Infectious Diseases|May 1, 1995
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working GroupA J Japour, S Welles, R T D'Aquila, et al.
The Journal of Infectious Diseases|August 1, 1977
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adultsD D Richman, B R Murphy, R B Belshe, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohortJ J Day, I Grant, J H Atkinson, et al.
AIDS (London, England)|December 17, 2009
Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressureWeerawat Manosuthi, David M Butler, Josué Pérez-Santiago, et al.
The Journal of Infectious Diseases|November 26, 2013
Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United StatesGabriel A Wagner, Mary E Pacold, Sergei L Kosakovsky Pond, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Nature Medicine|April 18, 2017
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapyJenna B Honeycutt, William O Thayer, Caroline E Baker, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|January 16, 2004
Drug resistance mutations in HIV-1Victoria A Johnson, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
Pageof 80

Showing results (411-420 of 792) with videos related to

Sort By:
Pageof 80
JAMA Oncology|October 28, 2017
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal CancerJenny F Seligmann, Ace J Hatch, Susan D Richman, et al.
The Journal of Infectious Diseases|May 1, 1995
Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working GroupA J Japour, S Welles, R T D'Aquila, et al.
The Journal of Infectious Diseases|August 1, 1977
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adultsD D Richman, B R Murphy, R B Belshe, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1992
Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohortJ J Day, I Grant, J H Atkinson, et al.
AIDS (London, England)|December 17, 2009
Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressureWeerawat Manosuthi, David M Butler, Josué Pérez-Santiago, et al.
The Journal of Infectious Diseases|November 26, 2013
Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United StatesGabriel A Wagner, Mary E Pacold, Sergei L Kosakovsky Pond, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Nature Medicine|April 18, 2017
HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapyJenna B Honeycutt, William O Thayer, Caroline E Baker, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|January 16, 2004
Drug resistance mutations in HIV-1Victoria A Johnson, Françoise Brun-Vézinet, Bonaventura Clotet, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
Pageof 80